HRTG trades 54.7% below Wall Street's consensus target of $36.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HRTG achieves its forward estimates and maintains a stable P/E multiple of 5.4x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Heritage Insurance Holdings, Inc. (HRTG) has a Wall Street consensus price target of $36.00, based on estimates from 9 covering analysts. With the stock currently trading at $23.27, this represents a potential upside of +54.7%. The company has a market capitalization of $706M.
Analyst price targets range from a low of $36.00 to a high of $36.00, representing a 0% spread in expectations. The median target of $36.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, HRTG trades at a trailing P/E of 3.7x and forward P/E of 5.4x. The forward PEG ratio of 0.07 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -34.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $49.77, with bear and bull scenarios of $31.35 and $65.57 respectively. Model confidence stands at 47/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
UPCUniverse Pharmaceuticals Inc. | $2M | $2.95 | — | — | — | — | — |
HCIHCI Group, Inc. | $2.1B | $163.63 | $126.50 | -22.7% | Buy | 9.4x | 14 |
PLMRPalomar Holdings, Inc. | $3.0B | $111.70 | $110.25 | -1.3% | Buy | 11.4x | 11 |
NODKNI Holdings, Inc. | $326M | $15.91 | — | — | — | — | — |
ACGLArch Capital Group Ltd. | $32.5B | $91.18 | $102.57 | +12.5% | Buy | 9.8x | 34 |
RLIRLI Corp. | $4.9B | $53.09 | $56.33 | +6.1% | Hold | 19.2x | 12 |
RNRRenaissanceRe Holdings Ltd. | $12.9B | $299.17 | $310.75 | +3.9% | Hold | 7.3x | 28 |
VRSKVerisk Analytics, Inc. | $22.8B | $173.80 | $226.11 | +30.1% | Hold | 22.7x | 25 |
IIIVi3 Verticals, Inc. | $438M | $19.82 | $28.00 | +41.3% | Buy | 17.4x | 15 |
FAFFirst American Financial Corporation | $7.0B | $68.63 | $83.00 | +20.9% | Buy | 10.2x | 15 |
Quick answers to the most common questions about buying HRTG stock.
The consensus Wall Street price target for HRTG is $36, representing 54.7% upside from the current price of $23.27. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HRTG has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $36 implies 54.7% upside from current levels.
With a forward P/E of 5.4116x, HRTG trades at a relatively low valuation. The consensus target of $36 implies 54.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $36 for HRTG, while the most conservative target is $36. The consensus of $36 represents the median expectation. Our quantitative valuation model projects a bull case target of $66 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HRTG is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HRTG stock forecast based on 9 Wall Street analysts shows a consensus price target of $36, with estimates ranging from $36 (bear case) to $36 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $50, with bear/bull scenarios of $31/$66.
Our quantitative valuation model calculates HRTG's fair value at $50 (base case), with a bear case of $31 and bull case of $66. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 47/100.
HRTG trades at a forward P/E ratio of 5.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 3.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HRTG, with a "Buy" consensus rating and $36 price target (54.7% upside). 5 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HRTG analyst price targets range from $36 to $36, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $36 consensus represents the middle ground. Our model's $31-$66 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.